Fig. 3.
Percentage of individuals who were totally abstinent (A), relapsed to a heavy drinking day (B) or reported alcohol-related problems on the DriInC (C) during the 16-week treatment period by treatment condition within participants who were homozygous for the Asn40 allele (n = 75), carriers of the Asp40 allele (N = 17), and for the total sample of genotyped participants (n = 92).